Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Immunohistochemistry Expression of Programmed Death-Ligand 1 in Colorectal Carcinoma among Nigerians.
Nigerian journal of clinical practice·2024
Immunohistochemical Study and Clinicopathologic Correlation of Cox-2 and Her-2 Expression in Colorectal Carcinoma: A 5-Year Retrospective Study.
West African journal of medicine·2022
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D.
Breast (Edinburgh, Scotland)·2022
Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Targeting Nrf2 in oxidative liver injury: expanding the role of gut microbiota and metabolites.
Journal of advanced research·2026
Recent Advances in Glucagon-Like Peptide-1 Receptor and Melanocortin-4 Receptor Agonists for the Treatment of Obesity and Type 2 Diabetes.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2026
Bacteroides acidifaciens enriched by KRAS mutation promotes colorectal tumorigenesis.
Cell host & microbe·2026